Bard (C.R.) and its subsidiaries provides medical, surgical, diagnostic and patient care devices. Co. has four product groups: vascular, which covers minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease; urology, which includes urology drainage products, fecal and urinary continence products, urological products and Targeted Temperature Management products; oncology, which covers devices used in the treatment and management of various cancers and other diseases and disorders; and surgical products, which includes implanted grafts and fixation devices for hernia and soft tissue repairs in addition to hemostats and surgical sealants. When considering the Bard (CR) Inc stock dividend history, we have taken known splits into account, such that the BCR dividend history is presented on a split-adjusted ("apples to apples") basis. Bard (CR) Inc dividend history is presented both in graphical/chart form, and as a BCR dividend history data table along the right-hand column.
|
BCR Stock Dividend HistoryThe BCR dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable BCR historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the BCR dividend history record. Also see the BCR stock dividend history data table along the right-hand column below. |
|
BCR Next Dividend Date » (Projection based upon history) Quotes delayed 20 minutes |
Hold (2.00 out of 4) 62nd percentile
(ranked higher than approx. 62% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
Projection: BCR Next Dividend Date Chart: BCR Chart - 5Yr Dividend Yield |